Literature DB >> 4577943

Treatment of "bacterial cystitis" in fully automatic machanical models simulating conditions of bacterial growth in the urinary bladder.

F O'Grady, I P Mackintosh, D Greenwood, B W Watson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4577943      PMCID： PMC2072600     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN： 0007-1021


× No keyword cloud information.
  8 in total

1.  The effect of osmolality on the response of Escherichia coli and Proteus mirabilis to penicillins.

Authors:  D Greenwood; F O'Grady
Journal:  Br J Exp Pathol       Date:  1972-10

2.  A comparison of the effects of ampicillin on Escherichia coli and proteus mirabilis.

Authors:  D Greenwood; F O'Grady
Journal:  J Med Microbiol       Date:  1969-11-04       Impact factor: 2.472

3.  Trimodal response of Escherichia coli and Proteus mirabilis to penicillins.

Authors:  D Greenwood; F O'Grady
Journal:  Nature       Date:  1970-10-31       Impact factor: 49.962

4.  A simple turbidity cell for continuously monitoring the growth of bacteria.

Authors:  B W Watson; C L Gauci; L Blache; F W O'Grady
Journal:  Phys Med Biol       Date:  1969-10       Impact factor: 3.609

5.  Chronic bacteriuria due to Escherichia coli. I. Assessment of the value of combined short- and long-term treatment with cycloserine, nitrofurantoin, and sulphadimidine.

Authors:  N W Ormonde; J A Gray; J M Murdoch; E Wallace; W Brumfitt; R Pursell; J W Regan
Journal:  J Infect Dis       Date:  1969-07       Impact factor: 5.226

6.  Synchronized micturition and antibiotic administration in treatment of urinary infection in an in vitro model.

Authors:  F O'Grady; J H Pennington
Journal:  Br Med J       Date:  1967-02-18

7.  Bacterial growth in an in vitro system simulating conditions in the urinary bladder.

Authors:  F O'Grady; J H Pennington
Journal:  Br J Exp Pathol       Date:  1966-04

8.  Kinetics of urinary tract infection. II. The bladder.

Authors:  F O'Grady; W R Cattell
Journal:  Br J Urol       Date:  1966-04
  8 in total
  15 in total

1.  Response of ampicillin resistant Escherichia coli to cephalosporins in an in vitro model simulating conditions of bacterial growth in the urinary bladder.

Authors:  D Greenwood; F O'Grady
Journal:  Br J Exp Pathol       Date:  1975-04

2.  Activity of cefazolin against dense populations of enterobacteria.

Authors:  D Greenwood; C H Chan-Teoh; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

3.  Factors influencing the response of Escherichia coli to antibiotics in conditions prevailing in the infected urinary bladder.

Authors:  D Greenwood; F O'Grady
Journal:  Br J Exp Pathol       Date:  1976-06

4.  Factors governing the emergence of resistance to nalidixic acid in treatment of urinary tract infection.

Authors:  D Greenwood; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

5.  Is your dosage really necessary? Antibiotic dosage in urinary infection.

Authors:  D Greenwood; F O'Grady
Journal:  Br Med J       Date:  1977-09-10

6.  The comparative performance of beta-lactam antibiotics against ampicillin sensitive Escherichia coli in conditions simulating those of the infected urinary bladder.

Authors:  D Greenwood; F O'Grady
Journal:  Br J Exp Pathol       Date:  1974-06

7.  Activity of FL 1060, a new beta-lactam antibiotic, against urinary tract pathogens.

Authors:  D Greenwood; H L Brooks; R Gargan; F O'Grady
Journal:  J Clin Pathol       Date:  1974-03       Impact factor: 3.411

8.  Dual-action cephalosporin utilizing a novel therapeutic principle.

Authors:  D Greenwood; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

9.  Combined action of decreasing concentrations of azlocillin and sisomicin on Pseudomonas aeruginosa as assessed in a dynamic in vitro model.

Authors:  I Haller
Journal:  Infection       Date:  1982       Impact factor: 3.553

10.  Urinary tract infection.

Authors:  D Greenwood; R Slack
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.